JNJ Stock Price - Johnson & Johnson logo

JNJ Stock Price

Johnson & Johnson

$252.01
+$3.40(+1.37%)
56
Overall
70
Value
50
Tech
50
Quality
How is this score calculated?
Market Cap
$635.56B
Volume
2.65M
52W Range
$184.66 - $281.07
Target Price
$282.76

JNJ stock price is $252.01 (+1.37% on the day), giving Johnson & Johnson a market cap of $635.56B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

JNJ Stock Overview

Price
$252.01
Previous close
$248.61
Open
$249.09
Market cap
$635.56B
P/E ratio
23.7
52-week range
$184.66 - $281.07
1-year price target
$282.76
Sector
Healthcare
Industry
Drug Manufacturers - Major
Exchange
NYE
MarketXLS Rank
56

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

ABCD
1SymbolPriceChangeVol
2JNJ$252.01+1.4%2.65M
3
4
5
6

Get Johnson & Johnson Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.